By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teijin Pharma 

1-1, Uchisaiwaicho 2-chome, Chiyoda-ku

Tokyo    100-8585  Japan
Phone: 81-42-581-4321 Fax:



Company News
Merck & Co. (MRK) Enters Exclusive Worldwide License Agreement With Teijin Pharma For Investigational Antibody Candidate Targeting Tau 5/25/2017 6:54:05 AM
Teijin Pharma Release: Company To Take Over Implantable Medical Product Company Of Takiron (TYO) To Expand Bone-Connecting Material Business 1/24/2017 10:20:44 AM
Teijin Pharma, Amgen (AMGN) To Jointly Research And Develop New Therapy For Kidney Diseases 12/20/2016 10:12:55 AM
Positive Phase II In Eosinophilic Asthma For Pulmagen/Teijin Pharma 12/14/2016 9:09:22 AM
Teijin Pharma Launches ReoGo-J Device In Japan For Upper-limb Stroke Survivors 11/4/2016 3:57:19 PM
Teijin Pharma Release: Supplemental Application Filed For Somatuline In Japan For Additional Indication Of Neuroendocrine Tumors 7/27/2016 9:29:24 AM
Teijin Pharma’s FEBURIC (Febuxostat) Approved As Indication For Cancer Chemotherapy-Induced Hyperuricemia 5/23/2016 12:42:52 PM
Teijin Pharma To Co-market New Anti-inflammatory Analgesic Patch Formulation 2/1/2016 9:33:09 AM
Teijin Pharma To Start Rental Service For SLEEPMATE 10 Continuous Positive Airway Pressure Device 1/29/2016 8:48:48 AM
Teijin Pharma Launches Patient-information Sharing System For Integrated Community-care Support Businesses 11/10/2015 10:13:31 AM